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Abstract (250 words) 1 
One of the major burdens on the livestock industry is loss of animals and decrease of production 2 
efficiency due to disease. Advances in sequencing technology and genome editing techniques provide 3 
the unique opportunity to generate animals with improved traits. In this review we discuss the 4 
techniques currently applied to genetic manipulation of livestock species and the efforts in making 5 
animals disease resistant or resilient.  6 
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Introduction 42 
With the world population predicted to reach almost 10 billion by 2050 there are a number of challenges 43 
in sustainable management of finite resources. The rising demand for food requires improved 44 
productivity of agricultural systems. One of the major burdens on the livestock industry is loss of 45 
animals and decrease of production efficiency due to disease. Furthermore, it is important to improve 46 
the health and welfare of animals by reducing and preferably preventing the effects of disease. Advances 47 
in sequencing technology and genome editing techniques provide the unique opportunity to generate 48 
animals with improved traits. In this review we will discuss the techniques currently applied to genetic 49 
manipulation of livestock species and the efforts in making animals disease resistant or resilient. 50 
The tools 51 
In 1982 Plamiter and Brinster (1) set the stage for sequential advances in our ability to modify and 52 
improve mammalian genomes for desirable traits. Whereas previous work by others showed that 53 
foreign DNA fragments could be integrated into the genome of embryos by pronuclear microinjection 54 
(PNI), their work demonstrated a functional application; introduction of a growth hormone gene into 55 
mouse embryos resulted in rapid growth of the animals. Beyond utilizing cell-based approaches, early 56 
genome modification was restricted to the injection of plasmids or gene fragments into the pronucleus 57 
of embryos. More efficient integration of foreign DNA fragments into the target genome was 58 
subsequently achieved using transposons or retroviral vectors (2, 3). Early specific edits in cells could 59 
be achieved with homing endonucleases (HE), natural meganucleases, which introduce double strand 60 
breaks (DSBs) at target recognition sites of 14-40bp (4). However, engineering of HEs has been 61 
challenging and they are prone to off-target cutting, wherefore there are currently still very few in vivo 62 
applications (5). The development of the zinc finger nuclease (ZFN) (6), the first genome editing tool, 63 
increased the repertoire of programmed modifications, allowing precise cutting and repair to any target 64 
genome. The intervening two decades have borne witness to the continued development of the editing 65 
toolbox, with improvements in adaptability and efficiency, coupled with reduced costs and facile in-66 
house assembly platforms, resulting in an almost exponential uptake of the technology in the last five 67 
years (Figure 1).   68 
Zinc Fingers (ZFs) are amongst the most well-characterised protein DNA binding domains (DBDs) found 69 
in nature. Each ZF binds a triplet of nucleotides, with synthetic arrays of ZFs constructed to improve 70 
specificity to a desired target sequence (typically 9-18 bases). ZFNs are chimeric enzymes created by 71 
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fusing a modular ZF array to the nuclease domain of the restriction enzyme FokI.  This nuclease domain 72 
has no innate sequence specificity, with target site delineated by the ZF array. The FokI nuclease domain 73 
requires dimerization to function, so paired ZFNs are typically employed to generate a targeted DNA 74 
DSB, further increasing site specificity. Unfortunately, the design of ZFNs remains a complicated and 75 
technically challenging process. Only a small number of companies have the expertise required to 76 
produce reliable ZFNs, and, as a result, these reagents have remained relatively expensive, curbing their 77 
wider use.    78 
Transcription activator-like effectors (TALEs) are a second group of naturally occurring proteins 79 
containing DBDs. Produced by proteobacteria of the genus Xanthomonas, TALEs bind host DNA and 80 
thereby alter the transcriptional profile of infected cells. The DNA binding portion of each TALE is 81 
composed of a repeated modular array, with each module having sequence preference for a single DNA 82 
base (7). This simple 1-to-1, module-to-base, relationship makes design of functional synthetic DBDs 83 
straight forward, and kits can be purchased to allow their assembly in a standard molecular biology lab 84 
in less than two weeks. Typically designed to recognise 12-20 bases, arrays are fused with FokI to give 85 
a TALE nuclease (TALEN), and, as with ZFNs, these are employed in pairs to allow FokI dimerization and 86 
increase specificity. Two sequential modifications to the FokI domain further reduced the potential for 87 
off-target cutting by both TALENs and ZFNs; conversion of the homodimer into an obligate heterodimer, 88 
and conversion from a nuclease to a nickase by mutation of a catalytic domain (8). However, while 89 
TALENs were certainly more widely utilised than ZFNs, they have since been superseded by the most 90 
recent tool.  91 
Developed from an innate bacterial antiviral mechanism, the latest addition to the genome editor 92 
toolbox is the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated 93 
(Cas) system. With target specificity directed by a short single-stranded RNA (ssRNA) molecule(s), this 94 
represents a departure from the preceding genome editors that utilise a protein-based DBD. As with the 95 
FokI nuclease domain, Cas nucleases lack innate sequence specificity but are instead guided to their 96 
target site by Watson-Crick base pairing between their complexed ssRNA and the cognate DNA 97 
sequence. This constitutes a major advantage for this tool; the Cas nuclease is not covalently fused to a 98 
DBD so the same protein can be utilised to target multiple different target sites simply by combining it 99 
with different combinations of ssRNA. Furthermore, while all of the reagents required can be produced 100 
in almost any molecular biology lab, both the Cas nuclease and the ssRNA molecules can also be 101 
purchased from multiple vendors. The ease with which reagents can be designed, coupled with 102 
economical availability, has resulted in huge uptake of this tool and an explosion of publications in this 103 
field. (9, 10) 104 
  105 
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The possibilities  106 
Genome editors can break DNA at specific target sites; it is through the subsequent repair of these 107 
breaks that scientists can introduce desired changes at the target locus. Most cell types preferentially 108 
utilise the non-homologous end-joining (NHEJ) pathway, an error-prone process that typically results 109 
in small insertions or deletions at the site of repair. By creating a DNA break in the coding sequence of a 110 
gene, this form of repair often generates a frameshift mutation and thereby truncation of the encoded 111 
protein or functional gene knockout (KO). Alternatively, by flooding the target cell with a DNA repair 112 
template, it is possible to trigger the homology-directed repair (HDR) pathway. This allows the 113 
introduction of precise sequence changes proximal to the cut site, ranging from single base changes to 114 
the insertion of transgenes. Researchers commonly use synthetic single stranded oligodeoxynucleotides 115 
to introduce small changes, or plasmid/dsDNA templates for larger insertions. Finally, by creating two 116 
simultaneous breaks on a chromosome the intervening DNA sequence can be deleted; this approach can 117 
be used to alter transcriptional profiles by removing regulatory elements, or to delete exons thereby 118 
removing protein domains while leaving the remaining reading frame intact. (11) 119 
As a result of the evolution of this technology and a greater understanding of how to harness its potential 120 
we are now able to introduce extremely precise changes to the genome with greater accuracy and 121 
efficiency than has ever been possible. We are now at a stage where we are limited more by our 122 
imagination than the technology available.  123 
The industry 124 
The long history of livestock domestication has relied on the sequential selection of animals based on 125 
desirable traits, with generational improvements in their ability to thrive in the varied habitats occupied 126 
by the communities farming them. Traditionally, selective breeding focused on handling and 127 
productivity traits, such as docility, feed conversion, and fertility, with modern breeding goals 128 
incorporating animal health and welfare. Selecting for disease resistance and resilience is not only 129 
important from an animal health and welfare perspective but has significant economic impacts. For 130 
instance, it is estimated that endemic diseases incur added costs of €30-40 per slaughter pig in the 131 
European Union, adding to up to €10.5bn per year ((12), EU28 2016 (13)).  132 
Livestock breeding companies incorporate genetic improvement into their programmes by assigning 133 
values to various traits of individual animals and incorporating only those with the highest overall merit 134 
into their nucleus herd. Advances in affordable genotyping tools allow direct linkage between 135 
physiological characteristics and genome-wide association studies (GWAS) (14), resulting in 136 
increasingly efficient and productive breeding populations. Compilation of phenotypic information is 137 
relatively straightforward when traits can be measured accurately under normal husbandry conditions. 138 
By contrast, disease susceptibility, or lack thereof, is a trait that is difficult to quantitatively assess as 139 
exposure to pathogens within a population of animals is rarely uniform and the deliberate exposure of 140 
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large numbers of animals under experimental conditions is both ethically questionable and very 141 
expensive (15). Even if such variance could be readily identified, the merit gains achieved by recent 142 
breeding programmes may prove a barrier to propagation within a nucleus herd; the allelic variant 143 
might be present in low abundance, recessive, or associated with animals that would otherwise be 144 
considered of low merit. In this scenario genome editing offers an opportunity to contribute to the 145 
natural breeding process, introducing newly identified genetic features into the progeny of elite nucleus 146 
animals without negatively impacting other highly desirable traits (16). Such an approach could also 147 
contribute to genetic improvement if relevant polymorphisms were identified in related breeds or even 148 
other species (Figure 2). As such, genome editors have great potential in allowing the introduction of 149 
novel traits that improve animal welfare, increase production, reduce food waste in the production 150 
chain, improve food security, and contribute to the economic security of small holder farmers. 151 
The animals 152 
Editing in cattle poses a significant challenge due to cost, small number of offspring, and long generation 153 
time (9 months gestation, 12-18 months to reach sexual maturity). As a consequence, there is significant 154 
pressure for editing techniques to be highly efficient to ensure intended offspring. While somatic cell 155 
nuclear transfer (SCNT) of confirmed edited cells is often the preferred option (17, 18) cytoplasmic 156 
microinjection (CPI) and PNI into in vitro fertilised oocytes have also been employed (19). While 157 
generation of chimeras by microinjection of edited induced pluripotent stem cells (iPSCs) into 158 
blastocysts has been demonstrated in multiple papers, so far no germline transmission was reported 159 
(20, 21). A potential future editing technique in cattle may also be the editing of spermatogonial stem 160 
cells (SSCs). Long-term cultivation methods have been recently published and advances in 161 
transplantation of these cells and sterile recipients could provide a promising avenue for generating 162 
genome edited cattle (22, 23).  163 
Editing goats and sheep is less restricted than cattle; they are smaller, cheaper, and produce more 164 
offspring and, with gestation times of 5 months and sexual maturity at 6-8 months, the generation times 165 
are significantly lower. Oocytes can be collected from abattoir samples or by laparoscopic ovum pick-166 
up, with in vitro fertilization (IVF) and microinjection of zygotes (24). In all ruminants blastocysts can 167 
be re-implanted into a recipient, allowing testing embryo viability and genotype prior to the 168 
implantation. Alternatively, small ruminants have also been generated by SCNT (25-27) and goats by 169 
sperm-mediated gene transfer (SMGT) (28). The generation of chimeric embryos from (non-edited) 170 
iPSCs has been demonstrated in sheep (29), whilst in goats the generation of iPSCs has been reported, 171 
no editing or chimeric integration has been demonstrated yet (30, 31). 172 
Pigs have several advantages over ruminants for genome modification; they have large litter sizes, a 173 
short gestation of less than 4 months, and can reach sexual maturity at 5-6 months. While many groups 174 
have successfully used SCNT to generate modified pigs, microinjection and transfer of zygotes is an 175 
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efficient alternative. As pigs are a multiparous species that self-limit the number of embryos they carry 176 
to term, an excess of manipulated zygotes can be transferred to each recipient to improve pregnancy 177 
rates. Zygotes are generally harvested from donor animals as polyspermy associated with IVF remains 178 
a significant issue (32). Genome modified animals have been produced using a variety of techniques, 179 
including SCNT and PNI and CPI of zygotes (comprehensive lists of modified animals can be found (33, 180 
34)). Germline transmission has been demonstrated in chimeric animals generated from iPSCs (35, 181 
36).A variety of cultivation methods for SSCs have been described in pigs, whereas long-term cultivation 182 
still remains a challenge (reviewed in (37)). Furthermore, genome edited, sterile recipients for the 183 
transfer of (edited) SSCs have been described in pigs (38). 184 
Editing in chicken has proven challenging compared to mammals due to significant differences in 185 
reproductive physiology. The germinal disk of a laid egg consists of approximately 50,000 cells leaving 186 
no clear route for efficient modification. Editing in chicken currently relies on primordial germ cells 187 
(PGCs) that are edited in vitro and transferred into recipient embryos. PGCs can be isolated, cultivated 188 
and genetically modified whilst maintaining their PGC status (39, 40). Transfer of PGCs to the blood 189 
stream of recipient embryos results colonisation of the developing gonad and subsequent germline 190 
transmission (41). With PGCs it is now possible to manipulate the genome of the chicken in culture and 191 
to use those cells to establish an edited chicken line. Furthermore, chicken PGCs may be modified by 192 
microinjection of transfection reagents and transposons into the blood stream of embryos to generate 193 
germline-modified animals (42).  194 
Whilst there has been a long history in management and breeding of the aforementioned animals, there 195 
are in fact numerous other livestock species that confer significant economic impact to the agricultural 196 
sector.  197 
The global consumption of farmed fish has recently overtaken beef and is the fastest growing animal 198 
protein production sector. Whilst selective breeding in fish is utilised for many species, targeted genome 199 
modification is in its infancy (43). Fish lay large numbers of eggs that are externally fertilised and 200 
thereby readily accessible for genetic manipulation. Early examples of transgenic fish are growth 201 
hormone transgenic salmon and Nile tilapia (44, 45). Genome edited salmon have been produced using 202 
CRISPR/Cas9 to induce albinism (46) or infertility (47). Both of these traits are of potential utility for 203 
Salmon breeders as albinism can serve as a visual editing indicator and sterility would prevent 204 
interbreeding of edited with wild salmon. Catfish were edited for enhanced growth by using 205 
CRISPR/Cas9 to knock out the myostatin gene (48). No genome editing for disease resistance has yet 206 
been reported in fish, however multiple GWAS studies are currently being conducted to identify such 207 
targets. A potential target region has been identified in salmon conferring resistance against pancreatic 208 
necrosis (49).  209 
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FAO lists honeybees as livestock as they are integral to many agricultural practices. Global impact of 210 
honeybees as pollinators in crop production is significant (50, 51). Selective breeding in bees is 211 
employed to select for hygienic, low disease burden colonies (52, 53). Edited or transgenic bees can be 212 
generated by microinjection of embryos (54, 55). As has been the case in many agricultural species early 213 
work involved the introduction of fluorescence markers into the genome (54). Application of genome 214 
editors thus far has been to identify gene function rather than to address disease resistance (55). With 215 
improvements in the understanding of the bee genome and more detailed association studies it is 216 
anticipated that genome editing for disease resistance in bees is in the future (56). 217 
The diseases 218 
Mastitis has a huge impact in the dairy industries. In the US it is the most common disease in dairy cattle 219 
resulting in estimated annual losses of $2bn. Globally, small ruminants also play an important role in 220 
the dairy industries with mastitis conferring a significant economic burden. Staphylococcus aureus is the 221 
most common pathogen to cause mastitis and there is a very low natural heritability of resilience to 222 
infection. In ruminants a number of similar transgenic strategies have been employed by generating 223 
animals producing enzymes inhibiting the growth of bacteria in the mammary gland. In cattle the 224 
antibiotic lysostaphin was introduced by SCNT resulting in secreted protein in their milk, capable of 225 
killing S.aureus (57). The milk from goats expressing human lysozyme was shown to inhibit the growth 226 
of mastitis-causing bacteria and Pseudomonas fragi, responsible for the cold-spoilage of milk (58, 59). 227 
Importantly, the growth of L. lactis, required for the making of processed dairy products, such as cheese, 228 
was not inhibited. 229 
Misfolding of the prion protein (PrP) is associated with neurogenerative diseases in many mammals. 230 
The accumulation of misfolded PrP plaques results in bovine spongiform encephalopathy (BSE) in cattle 231 
and scrapie in sheep and goats. A number of different groups have knocked out the PrP gene as a strategy 232 
to circumvent such diseases.  While a transgenic approach has been used to achieve this goal, application 233 
of genome editors could be used streamline this process. In addition to value to the agricultural sector, 234 
interest in PrP KO livestock extends to biopharmaceuticals, as this is considered an appropriate safety 235 
measure of products destined for human applications (60-63).  236 
Early efforts are ongoing to make ruminants resilient to Mannheimia (Pasteurella) haemolytica infection, 237 
which causes epizootic pneumonia (shipping fever) and may also contribute to enzootic pneumonia in 238 
calves and lambs as well as peritonitis in sheep. The pathogen can produce a cytotoxic leukotoxin, which 239 
is largely responsible for the pathogenicity of the bacteria. In ruminants the leukotoxin binds to the 240 
uncleaved signal peptide of the CD18 protein present on the cell surface leukocytes (64). In other 241 
species, including mouse and human, the mature CD18 lacks the signal peptide as a result of proteolytic 242 
processing. Based on the human sequence, ZFNs were used to introduce a single amino acid change. 243 
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Leukocytes from the resultant foetuses were resistant to cytotoxicity associated with M.haemolytica 244 
leukotoxin (65). 245 
Bovine tuberculosis (bTB) has a direct effect on productivity in cattle and buffalo, impacts international 246 
trade, and poses a significant human health risk. Polymorphisms in the NRAMP1 gene, also known as 247 
SLC11A1, in cattle have been associated with varying levels of resilience to bTB infection (66). 248 
CRISPR/Cas9 was used for targeted insertion of an NRAMP1 variant associated with resilience to bTB 249 
infection into the cattle genome. Ex vivo challenge of peripheral blood monocytes showed reduced 250 
pathogen growth in exogenous NRAMP1 expressing cells. An in vivo study in the transgenic animals 251 
reported diminished interferon response to TB infection but did not assess pathogen burden (67).  252 
African Swine Fever Virus (ASFV) is a disease endemic to huge swathes of sub-Saharan Africa. Native 253 
suid hosts, including the warthog, are resilient to the infection, while domestic pigs develop a lethal 254 
haemorrhagic fever. Species-specific variation of the RELA, a component of the transcription factor NF-255 
κb, between native and domestic suids were postulated to underlie this host genetic variance (68). Using 256 
a ZFN pair with a plasmid template for HDR, researchers converted the encoded domestic pig protein 257 
sequence to the warthog equivalent (69). Data to show resilience of the animals to ASFV infection has 258 
yet to be reported. It is important to differentiate between disease resistance, the ability of an animal to 259 
suppress the establishment and/or development of an infection, and disease resilience where an 260 
infected host manages to maintain an acceptable level of productivity despite challenge pressure (70). 261 
Should these pigs prove to be resilient to ASFV infection it is likely that their use may not be permitted 262 
in many jurisdictions, since they could act as reservoirs of infection. However, in environments where 263 
the disease is endemic use of such animals could be beneficial. 264 
The most economically important pig disease worldwide is porcine reproductive and respiratory 265 
syndrome (PRRS). In vitro experiments showed that entry of the causative agent of the disease, PRRS 266 
virus (PRRSV), into host cells relies on two proteins, CD163 and CD169 (71). It was further 267 
demonstrated that subdomain 5 of CD163 was essential for PRRSV entry (72). Surprisingly, SCNT with 268 
fibroblasts lacking CD169 resulted in pigs that were not resistant to PRRSV infection (73). Functional 269 
CD163 KO animals were generated using a CRISPR/Cas9 to induce a NHEJ-mediated premature stop 270 
codon (74). The CD163 KO animals were shown to be resistant to PRRSV infection both in vitro and in 271 
vivo (75). CD163 has a wide variety of important biological functions in inflammation and immune 272 
response. To retain these functions precise deletion of only CD163 subdomain 5 has been carried out. 273 
Subdomain 5 is encoded by exon 7, which was excised from the genome using CPI of two guide RNAs 274 
targeting the flanking intronic sequence. Cells from the resulting animals are resistant to PRRSV 275 
infection and maintain their biological function (76). 276 
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Reactivation of endogenous retroviruses is a potential barrier to the use of livestock as tissue and organ 277 
donors. Genome editors have been used to permanently inactivate porcine endogenous retrovirus in 278 
pigs presenting a potential solution to this human health threat (77). 279 
Avian influenza poses a significant threat to the global poultry industry and to human health, as zoonotic 280 
transmission is frequently observed. The control of outbreaks requires the culling of infected and 281 
neighbouring flocks and the implementation of strict biosecurity measure to prevent the further spread 282 
of the virus. Transgenic chickens were generated by microinjection of eggs with retrovirus to 283 
incorporate a small decoy RNA fragment under a U6 promoter into the chicken genome (78). The decoy 284 
RNA fragment expressed in chickens interferes with the formation of infectious influenza particles, 285 
thereby preventing spread to co-housed birds. This approach has yet to be evaluated in other species 286 
susceptible to influenza. 287 
Discussion and Outlook 288 
Application of genome editors allows easy-to use, targeted strategies for genome modification in 289 
livestock. To improve disease resistance traits, editing targets are identified by investigation of in vitro 290 
host-pathogen interactions, species variation, or GWAS studies (Figure 3). The field of genome editors 291 
is fast evolving and sequential improvements coupled with a better understanding of DSB repair 292 
mechanisms will inevitably result in an expanded range of editing opportunities. Advances in delivery 293 
techniques, such as editing gametes or spermatogonial, embryonic, or induced pluripotent stem cells, 294 
will streamline the production of edited animals and make it applicable to a wider range of species. 295 
Generating disease resistant animals will not only help to feed the world but also improve animal 296 
welfare and aid in the reduction of antimicrobial use.  297 
Most of the examples discussed in this review are still at early stages and integration of genome edited 298 
animals into highly productive elite breeding lines will take time. Furthermore, approval of edited 299 
animals for human consumption relies on national and multi-national legislation, which is currently at 300 
early stages. And in the end, also the consumer will decide on the success of genome edited animals in 301 
livestock production. 302 
 303 
  304 
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Figure Legends 500 
 501 
Figure 1: Genome editing tools. By transfection of plasmids, transposons or DNA fragments and 502 
random or homology-directed integration foreign DNA fragments or modifications may be introduced 503 
into a target genome. Retroviruses or single-round infectious retroviruses may be used to integrate 504 
foreign genes at random sites into the target genome. Homing endonucleases, zinc finger nucleases 505 
(ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced 506 
palindromic repeats (CRISPR)/Cas9 are genome editors relying on enzymatic activity to introduce a 507 
targeted double strand break in the genome. Repair of these double strand breaks can lead to non-508 
homologous end joining events, resulting in insertion or deletions. A combination of genome editors 509 
with DNA fragments, plasmids or transposons can be used to enhance the efficiency of homology-510 
directed repair to integrate foreign genes or modify single base pairs at a specific locus in the genome. 511 
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Figure 2:  Techniques to generate genome-manipulated animals. Using genome editing tools a 513 
variety of techniques are available for the generation of genome edited animals. Sperm-mediated gene 514 
transfer (SMGT) is used for the delivery of genome editing reagents to the zygote. Furthermore, 515 
spermatogonial stem cell (SSC) or primordial germ cell (PGC) manipulation offer new avenues to 516 
generate edited animals. Pronuclear and cytoplasmic injection of genome editors into zygotes and 517 
subsequent transfer to surrogates or maturation in incubators prior to transfer may be used to generate 518 
genome-manipulated animals. Somatic cell nuclear transfer allows the selection of specific edits in 519 
somatic cells prior to nuclear transfer to surrogates or maturation in incubators. The injection of edited 520 
embryonic or induced pluripotent stem cells into blastocysts can also be used to generate chimeric 521 
edited animals. 522 
  523 
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 524 
Figure 3:  Research paths to identify editing targets for disease resistance. Identification of 525 
sequence variation associated with susceptibility to disease state allows for the identification of 526 
potential editing targets. Genome-wide association studies (GWAS) allow high throughput comparisons 527 
between large numbers of animals of the same species. Hypothesis-driven analysis of specific gene 528 
sequences can be used to identify species variance associated with disease resistance. In a laboratory 529 
setting in vitro host-pathogen interaction studies can be used to identify pathways amenable to 530 
interventions. Genome-wide screening methods, such as small-interfering RNA (siRNA) or genome-531 
scale CRISPR knock-out (GeCKO), allow for the identification of a large number of proteins required for 532 
pathogen replication. Hypothesis-driven strategies rely on a prior knowledge of specific host-pathogen 533 
interactions. 534 
